<?xml version="1.0" encoding="UTF-8"?>
<rootTag>
<Award>
<AwardTitle>SGER: Biophotonics for Diagnosis of Pancreatic Cancer</AwardTitle>
<AwardEffectiveDate>07/01/2007</AwardEffectiveDate>
<AwardExpirationDate>12/31/2008</AwardExpirationDate>
<AwardTotalIntnAmount>0.00</AwardTotalIntnAmount>
<AwardAmount>160349</AwardAmount>
<AwardInstrument>
<Value>Standard Grant</Value>
</AwardInstrument>
<Organization>
<Code>07020000</Code>
<Directorate>
<Abbreviation>ENG</Abbreviation>
<LongName>Directorate For Engineering</LongName>
</Directorate>
<Division>
<Abbreviation>CBET</Abbreviation>
<LongName>Div Of Chem, Bioeng, Env, &amp; Transp Sys</LongName>
</Division>
</Organization>
<ProgramOfficer>
<SignBlockName>Leon Esterowitz</SignBlockName>
</ProgramOfficer>
<AbstractNarration>CBET-0733868 Backman  Pancreatic cancer (PC) has the worst prognosis of any major cancer, with a five-year survival rate below 5%. The reasons for the lethality of PC relates to its tendency to be&lt;br/&gt;diagnosed at a late stage given that potentially curable stages of disease are often&lt;br/&gt;clinically silent. Survival rate dramatically depends on the stage at which PC is&lt;br/&gt;diagnosed. However, pancreatic cancer is insidious in that the development of symptoms&lt;br/&gt;generally portend unresectable and hence uncurable disease. One of the major hurdles&lt;br/&gt;preventing screening for PC is that essentially any interrogation of the pancreas may lead&lt;br/&gt;to serious complications (~20% complication rate). Thus, finding a pre-screening method in&lt;br/&gt;which patients are risk-stratified would be critical for designing screening strategies.&lt;br/&gt;This project focuses on development of a biophotonics approach (a partial wave spectroscopic microscopic technique), to address this problem.&lt;br/&gt;</AbstractNarration>
<MinAmdLetterDate>05/01/2007</MinAmdLetterDate>
<MaxAmdLetterDate>06/06/2008</MaxAmdLetterDate>
<ARRAAmount/>
<AwardID>0733868</AwardID>
<Investigator>
<FirstName>Vadim</FirstName>
<LastName>Backman</LastName>
<EmailAddress>v-backman@northwestern.edu</EmailAddress>
<StartDate>05/01/2007</StartDate>
<EndDate/>
<RoleCode>Principal Investigator</RoleCode>
</Investigator>
<Investigator>
<FirstName>Randall</FirstName>
<LastName>Brand</LastName>
<EmailAddress>rbrand@enh.org</EmailAddress>
<StartDate>05/01/2007</StartDate>
<EndDate/>
<RoleCode>Co-Principal Investigator</RoleCode>
</Investigator>
<Investigator>
<FirstName>Hemant</FirstName>
<LastName>Roy</LastName>
<EmailAddress>h-roy@northwestern.edu</EmailAddress>
<StartDate>05/01/2007</StartDate>
<EndDate/>
<RoleCode>Co-Principal Investigator</RoleCode>
</Investigator>
<Institution>
<Name>Northwestern University</Name>
<CityName>Chicago</CityName>
<ZipCode>606114579</ZipCode>
<PhoneNumber>3125037955</PhoneNumber>
<StreetAddress>750 N. Lake Shore Drive</StreetAddress>
<CountryName>United States</CountryName>
<StateName>Illinois</StateName>
<StateCode>IL</StateCode>
</Institution>
<FoaInformation>
<Code>0000099</Code>
<Name>Other Applications NEC</Name>
</FoaInformation>
<ProgramElement>
<Code>7236</Code>
<Text>BioP-Biophotonics</Text>
</ProgramElement>
<ProgramReference>
<Code>0000</Code>
<Text>UNASSIGNED</Text>
</ProgramReference>
<ProgramReference>
<Code>005E</Code>
<Text>Neuro-photonics</Text>
</ProgramReference>
<ProgramReference>
<Code>7237</Code>
<Text>NANO NON-SOLIC SCI &amp; ENG AWD</Text>
</ProgramReference>
<ProgramReference>
<Code>9237</Code>
<Text>SMALL GRANTS-EXPLORATORY RSRCH</Text>
</ProgramReference>
<ProgramReference>
<Code>OTHR</Code>
<Text>OTHER RESEARCH OR EDUCATION</Text>
</ProgramReference>
</Award>
</rootTag>
